CT-2584 - CAS 166981-13-1

CT-2584 is an anticancer agent that inhibits phospholipid signaling and kills tumor cells through the production of reactive oxygen intermediates. CT-2584 reduces NKEF-B expression in several tumor cell types. CT-2584 reduced tumor growth in SCID mice by causing shunting of ab initio phospholipid biosynthesis from phosphatidylcholine (PC) to phosphatidylinositol (PI) via PA.

Reactive Oxygen Species, ROS

Immunology/Inflammation, NF-κB, Metabolism

166981-13-1

0.9977

C30H55N5O3

533.79

O=C1C2=C(N=CN2C)N(C(=O)N1CCCCCCCCCC(O)CNCCCCCCCCCCCC)C

-20°C

Ice Packs

Small Compound